End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Degtyarev E, Bolaños N, Brody JD, Buchbinder A, Buyse M, Fuchs M, Halabi S, Hemmings R, Masood A, Newsome S, Saxton C, Warwick L, Yateman NA, Zuber E.
Degtyarev E, et al. Among authors: yateman na.
Future Oncol. 2024;20(22):1601-1615. doi: 10.1080/14796694.2024.2357537. Epub 2024 Jun 18.
Future Oncol. 2024.
PMID: 38889345
Free PMC article.